Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Investigating the Effects of QVM149 on MRI Ventilation Defects
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
- Status
- TERMINATED
- Phase
- PHASE3
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE3
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Status
- RECRUITING
- Phase
- N/A
Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
- Status
- TERMINATED
- Phase
- PHASE2
A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)
- Status
- TERMINATED
- Phase
- PHASE2
Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of Capmatinib (INC280) Plus Pembrolizumab vs Pembrolizumab Alone in NSCLC With PD-L1≥ 50%
- Status
- TERMINATED
- Phase
- PHASE2
Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE2
A Study of WVT078 in Patients With Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE1
Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
- Status
- WITHDRAWN
- Phase
- PHASE3
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
- Status
- RECRUITING
- Phase
- PHASE3
An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2